Zacks: Analysts Anticipate Amdocs Limited (DOX) Will Announce Quarterly Sales of $977.54 Million
Analysts expect Amdocs Limited (NASDAQ:DOX) to post $977.54 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Amdocs Limited’s earnings. The highest sales estimate is $982.57 million and the lowest is $974.94 million. Amdocs Limited reported sales of $940.66 million in the same quarter last year, which would suggest a positive year over year growth rate of 3.9%. The company is expected to announce its next quarterly earnings results on Tuesday, November 14th.
According to Zacks, analysts expect that Amdocs Limited will report full-year sales of $977.54 million for the current year, with estimates ranging from $3.86 billion to $3.87 billion. For the next financial year, analysts anticipate that the business will post sales of $4.00 billion per share, with estimates ranging from $3.98 billion to $4.03 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Amdocs Limited.
Amdocs Limited (NASDAQ:DOX) last announced its quarterly earnings data on Wednesday, August 2nd. The technology company reported $1.02 EPS for the quarter, topping the consensus estimate of $0.96 by $0.06. The company had revenue of $967.00 million during the quarter, compared to the consensus estimate of $967.04 million. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.75%. The company’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.90 EPS.
Several brokerages recently weighed in on DOX. Barclays PLC reaffirmed a “hold” rating and issued a $68.00 price target on shares of Amdocs Limited in a research note on Friday, August 4th. Zacks Investment Research raised Amdocs Limited from a “hold” rating to a “buy” rating and set a $75.00 target price on the stock in a report on Friday, August 4th. Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $70.00 target price on shares of Amdocs Limited in a report on Tuesday, September 5th. BidaskClub raised Amdocs Limited from a “sell” rating to a “hold” rating in a report on Tuesday, August 1st. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $59.00 target price on shares of Amdocs Limited in a report on Friday, June 16th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $67.63.
Shares of Amdocs Limited (NASDAQ DOX) traded down 1.45% during mid-day trading on Thursday, hitting $62.49. 5,138,550 shares of the stock traded hands. Amdocs Limited has a 52 week low of $54.91 and a 52 week high of $67.98. The stock has a market cap of $9.08 billion, a price-to-earnings ratio of 21.77 and a beta of 0.53. The firm’s 50-day moving average is $64.29 and its 200-day moving average is $63.44.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date is Thursday, September 28th. Amdocs Limited’s payout ratio is currently 30.66%.
Several large investors have recently made changes to their positions in DOX. Robecosam AG bought a new position in shares of Amdocs Limited during the first quarter valued at $114,000. BB&T Investment Services Inc. bought a new position in shares of Amdocs Limited during the second quarter valued at $118,000. Acrospire Investment Management LLC bought a new position in shares of Amdocs Limited during the second quarter valued at $155,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Amdocs Limited by 30.6% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,969 shares of the technology company’s stock valued at $181,000 after purchasing an additional 696 shares in the last quarter. Finally, Atria Investments LLC bought a new position in Amdocs Limited in the second quarter valued at about $218,000. 89.31% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: This news story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/09/17/zacks-analysts-anticipate-amdocs-limited-dox-will-announce-quarterly-sales-of-977-54-million.html.
About Amdocs Limited
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related stocks with our FREE daily email newsletter.